Artiva Biotherapeutics annual revenue
2022
2023
2024
2025
Artiva Biotherapeutics Revenue Growth & History (ARTV)
Artiva Biotherapeutics reported $0 in revenue for fiscal 2025, a decrease of 100.00% from the previous fiscal year.
View full Artiva Biotherapeutics company overviewArtiva Biotherapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | −$251,000 | −100.00% |
| 2024 | 2024-12-31 | $251,000 | −$32.7M | −99.24% |
| 2023 | 2023-12-31 | $32.9M | $28.0M | +567.67% |
| 2022 | 2022-12-31 | $4.9M | — | — |
Artiva Biotherapeutics quarterly revenue
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | — | — |
| Q4 2025 | 2025-12-31 | $0 | $0 | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q4 2024 | 2024-12-31 | $0 | — | — |
| Q3 2024 | 2024-09-30 | $0 | −$26.7M | −100.00% |
| Q2 2024 | 2024-06-30 | $0 | −$3.5M | −100.00% |
| Q1 2024 | 2024-03-31 | $251,000 | — | — |
| Q3 2023 | 2023-09-30 | $26.7M | — | — |
| Q2 2023 | 2023-06-30 | $3.5M | — | — |
Artiva Biotherapeutics revenue growth trends
Artiva Biotherapeutics's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Artiva Biotherapeutics source filings ↗